Simplex Trading
DFTX

Simplex Trading’s Definium Therapeutics DFTX Stock Holding History

Simplex Trading’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.83M Buy
39,000
+25,300
+185% +$625K ﹤0.01% 2134
2026
Q1 		$259K Sell
13,700
-72,600
-84% -$1.23M ﹤0.01% 3991
2025
Q4 		$1.16M Sell
86,300
-23,000
-21% -$285K ﹤0.01% 2491
2025
Q3 		$1.29M Sell
109,300
-9,100
-8% -$84.9K ﹤0.01% 2785
2025
Q2 		$768K Sell
118,400
-9,600
-8% -$63.1K ﹤0.01% 3062
2025
Q1 		$748K Sell
128,000
-36,900
-22% -$264K ﹤0.01% 2982
2024
Q4 		$1.15M Buy
164,900
+75,400
+84% +$519K ﹤0.01% 2708
2024
Q3 		$509K Buy
89,500
+35,700
+66% +$248K ﹤0.01% 3575
2024
Q2 		$387K Sell
53,800
-83,600
-61% -$731K ﹤0.01% 3928
2024
Q1 		$1.29M Sell
137,400
-186,000
-58% -$1.06M ﹤0.01% 2854
2023
Q4 		$375K Buy
323,400
+8,200
+3% +$24.7K ﹤0.01% 3996
2023
Q3 		$986K Sell
315,200
-9,200
-3% -$37.8K ﹤0.01% 2676
2023
Q2 		$1.16M Buy
324,400
+9,900
+3% +$34.1K ﹤0.01% 2470
2023
Q1 		$996K Sell
314,500
-355,800
-53% -$1.18M ﹤0.01% 2590
2022
Q4 		$1.47M Sell
670,300
-51,200
-7% -$142K ﹤0.01% 2113
2022
Q3 		$2.52M Buy
721,500
+691,260
+2,286% +$6.64M ﹤0.01% 1757
2022
Q2 		$290K Buy
30,240
+300
+1% +$3.8K ﹤0.01% 4140
2022
Q1 		$498K Sell
29,940
-5,173
-15% -$89.7K ﹤0.01% 3849
2021
Q4 		$726K Buy
35,113
+27,113
+339% +$865K ﹤0.01% 3315
2021
Q3 		$411K Buy
8,000
+20
+0.3% +$865 ﹤0.01% 4395
2021
Q2 		$412K Buy
+7,980
New +$419K ﹤0.01% 4460

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Simplex Trading's DFTX Position: Q2 2026 in Review

Simplex Trading increased its Definium Therapeutics (DFTX) stake by 16% in Q2 2026, buying an estimated $160K and bringing the position to 47,651 shares worth $2.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1922.

Simplex Trading first reported a position in DFTX in Q2 2021 and has held it in 17 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Simplex Trading held 47,651 shares of Definium Therapeutics worth $2.24M as of Q2 2026.
  • Simplex Trading bought 6,495 Definium Therapeutics shares in Q2 2026, an estimated $160K.
  • Definium Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #1922 holding.
  • Simplex Trading first reported a position in Definium Therapeutics in Q2 2021 and has held it in 17 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.